157 related articles for article (PubMed ID: 6872348)
1. Effects of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice.
Shear HL; Wofsy D; Talal N
Clin Immunol Immunopathol; 1983 Mar; 26(3):361-9. PubMed ID: 6872348
[TBL] [Abstract][Full Text] [Related]
2. Hormone control of autoantibodies to calf thymus nuclear extract (CTE) and DNA in MRL-lpr and MRL-+/+ mice.
Brick JE; Walker SE; Wise KS
Clin Immunol Immunopathol; 1988 Jan; 46(1):68-81. PubMed ID: 3257179
[TBL] [Abstract][Full Text] [Related]
3. Defects in mononuclear phagocytic system (MPS) function in autoimmune MRL-lpr/lpr mice.
Jones FS; Pisetsky DS; Kurlander RJ
Clin Immunol Immunopathol; 1985 Jul; 36(1):30-9. PubMed ID: 3874027
[TBL] [Abstract][Full Text] [Related]
4. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
5. Induction of autoantibodies in normal mice by injection of nucleobindin and natural occurrence of antibodies against nucleobindin in autoimmune MRL/lpr/lpr mice.
Kanai Y; Takeda O; Miura K; Amagai M; Kaneko T; Kubota T; Kanai Y; Tanuma S; Kurosawa Y
Immunol Lett; 1995 Feb; 45(1-2):35-42. PubMed ID: 7622185
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune MRL/lpr mice sera contain IgG with interleukin 3-like activity.
Ohta Y; Tamura S; Tezuka E; Sugawara M; Imai S; Tanaka H
J Immunol; 1988 Jan; 140(2):520-5. PubMed ID: 3257242
[TBL] [Abstract][Full Text] [Related]
7. Suppressor T-cell activity in MRL/Mp-lpr/lpr mice: differential effects on primary and memory antibody responses of MRL/Mp-lpr/lpr and MRL/Mp-+/+ spleen cells to thymus dependent and thymus independent antigens in vitro.
Wilson DA
Cell Immunol; 1985 Dec; 96(2):312-26. PubMed ID: 2943418
[TBL] [Abstract][Full Text] [Related]
8. MRL mice show an age-related impairment of IgG aggregate removal from the circulation.
Field M; Brennan FM; Melsom RD; McCarthy D; Mumford P; Maini RN
Clin Exp Immunol; 1985 Jul; 61(1):195-202. PubMed ID: 4042418
[TBL] [Abstract][Full Text] [Related]
9. [Studies on abnormal immune responses to thymus-dependent antigens in autoimmune MRL/MpJ-lpr/lpr mice].
Kobayashi S
Hokkaido Igaku Zasshi; 1987 May; 62(3):451-60. PubMed ID: 2956175
[TBL] [Abstract][Full Text] [Related]
10. Interstitial pneumonitis in autoimmune MRL/lpr mice and its treatment with cyclosporin A.
Okudaira H; Ogita T; Miyamoto T; Shiga J; Suko M; Okudaira K; Terada E; Ghoda A; Terada K; Saito M
Clin Immunol Immunopathol; 1986 Jan; 38(1):47-54. PubMed ID: 3940742
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of GM1 on lymph node cells of MRL/Mp-lpr/lpr mice: influences on the autoreactivities of anti-asialo GM1 antibodies.
Ishii N; Watanabe K
Autoimmunity; 1992; 13(2):107-16. PubMed ID: 1467432
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
[TBL] [Abstract][Full Text] [Related]
13. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.
Nose M; Nishimura M; Kyogoku M
Am J Pathol; 1989 Aug; 135(2):271-80. PubMed ID: 2782373
[TBL] [Abstract][Full Text] [Related]
14. Lupus erythematosus cell formation by a monoclonal antibody derived from an autoimmune MRL/Mp-lpr/lpr mouse.
Kanai Y; Yamauchi S; Hashiba-Kanai Y
Immunol Lett; 1989 Jan; 20(1):9-13. PubMed ID: 2469647
[TBL] [Abstract][Full Text] [Related]
15. Marked acceleration of the autoimmune disease in MRL-lpr/lpr mice by the influence of the Yaa gene from BXSB mice.
Miyawaki S; Nakamura Y; Takeshita T; Yoshida H; Shibata Y; Mitsuoka S
Lab Anim Sci; 1988 Jun; 38(3):266-72. PubMed ID: 2970562
[TBL] [Abstract][Full Text] [Related]
16. Antibody feedback regulation in MRL/lpr mice.
Heyman B; Gustavsson S; Kusakari C; Nose M; Kinoshita T; Klareskog L; Tarkowski A
J Autoimmun; 1993 Aug; 6(4):437-48. PubMed ID: 8216687
[TBL] [Abstract][Full Text] [Related]
17. Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice.
Mizuochi T; Hamako J; Nose M; Titani K
J Immunol; 1990 Sep; 145(6):1794-8. PubMed ID: 2391420
[TBL] [Abstract][Full Text] [Related]
18. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice.
Jabs DA; Kuppers RC; Saboori AM; Burek CL; Enger C; Lee B; Prendergast RA
Cell Immunol; 1994 Mar; 154(1):66-76. PubMed ID: 7907009
[TBL] [Abstract][Full Text] [Related]
19. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
Meryhew NL; Shaver C; Messner RP; Runquist OA
J Lab Clin Med; 1991 Mar; 117(3):181-93. PubMed ID: 2002275
[TBL] [Abstract][Full Text] [Related]
20. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
Weston KM; Yeh ET; Sy MS
J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
